NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   Medications & Treatments (https://www.neurotalk.org/medications-and-treatments/)
-   -   Ncs / Paxil Question (https://www.neurotalk.org/medications-and-treatments/29901-ncs-paxil-question.html)

lyssajoan88 10-10-2007 10:07 PM

Ncs
 
Hi i am an 18 year old female. Today i was diagnosed with NCS or Nuerocardiogenic Syncope. I have a highly severe case of this syndrome and must be medicated. My physician is putting me on Paxil an anti-depressant that also eliminates NCS symptoms. I am really upset about having to go on it. I am just looking for some outside information on this drug and how it will help with my NCS.

Thanks
Alyssa

mrsD 10-11-2007 05:01 PM

here...
 
is an answer to a similar question from the Cleveland Clinic (by a doctor)

http://www.medhelp.org/forums/cardio...ges/32270.html

And this one has references to other websites:

http://www.medhelp.org/forums/cardio...ges/33169.html

Pamster 10-13-2007 08:30 AM

What kind of info do you have on paxil as a AD mrsd? Can you link me to some info on it?

mrsD 10-13-2007 09:45 PM

I have looked further on this subject and found
 
This paper. Evidently doctors are relying on only one study, which has
not been successfully duplicated:

http://www.escardio.org/knowledge/ca...2/vol2no27.htm

In my experience, Midodrine is typically tried. But it can have severe side effects, esp when lying down. Midodrine is used for severe orthostatic hypotension.
Quote:

Paroxetine (serotonin reuptake inhibitors) has been shown to be effective in one placebo-controlled open-label trial (12) which included a small number of highly symptomatic patients in one institution, but failed to show a significant effect on baroreflex control of sympathetic nerve activity in a double-blind randomised 6-month follow study performed in healthy subjects (13). Until the study is confirmed by others, use of this drug cannot be recommended.
Transdermal scopolamine was ineffective for the prevention of neurally-mediated syncope in a randomised placebo controlled evaluation performed in 60 patients (14): during follow-up syncope recurred in 79% of patients with scopolamine and in 75% of patients with placebo.

mrsD 10-13-2007 10:06 PM

this will
 
Quote:

Originally Posted by Pamster (Post 157412)
What kind of info do you have on paxil as a AD mrsd? Can you link me to some info on it?

scare the beejeebers out of most people... so visit at your own risk:
http://www.paxilprogress.org/forums/

There is some good information there, but it is obvious that most do not like Paxil at all. And many considered it harmful.

Paxil has been bypassed today in sales by Lexapro which is an SSRI.
But when the oldest SSRIs were put on the market, very little was understood
about them. Today, we still have conflicting theories on how they work, or if they work at all. (some studies have shown placebo as effective).

You can go on Rxlist.com and read the official copy of the drug insert. But it will not tell you what happens to real people, behavior-wise.

I myself had a spate of serious depression last winter, and I chose light therapy once a day and it worked.

L-tryptophan is now readily available. This taken at bedtime with some carbohydrate and B6, can help you make your own serotonin.

Pamster 10-14-2007 08:51 AM

Thanks mrsd, I will see if I can visit that forum. Isn't L-tryptophan that stuff in turkey that makes us sleepy? It sounds familar. Thanks for the information and all, I really appreciate it. :)

anasazi23 10-15-2007 01:27 PM

paxil
 
Of the SSRI's, Paxil is the most sedating, anticholinergic and causes weight gain. For a heart condition, I would choose something like lexapro. Paxil is also the drug that skewed the data to show increased suicidality in kids as it was by far the worst offender, although still minimal.


All times are GMT -5. The time now is 02:40 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.